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Meningococcal disease in travelers: A problem more than
a 100 years old
L. De Tora, L. Da Silva ∗
Novartis Vaccines and Diagnostics, Cambridge, MA, USA
Background: The risk of meningococcal disease to trav-
elers has been of increased interest in the past few
decades due to the well-known risk in Hajj pilgrims fol-
lowing outbreaks of invasive disease caused by serogroup
W-135. In addition, cases have been associated with air
travel Currently, preventive vaccination against appropri-
ate serogroups is recommended for travelers to regions with
hyperendemic or epidemic disease such as the ‘‘meningitis
belt’’ in Africa.
Methods: As part of an ongoing project on the history of
meningococcal disease in Novartis Vaccines and Diagnostics,
we investigated the occurrence of invasive disease in trav-
elers in historical documents and recent historical reviews
gleaned from various sources, including Medline, Google,
and Web of Science. Disease entities such as sinking typhus,
cerebral typhus, spotted fever, cerebrospinal fever, epi-
demic cerebro-spinal meningitis, which have been strongly
associated with meningococcal disease, were investigated.
Results: Several case histories and historical events place
meningococcal disease as a recognized risk of travel in the
late nineteenth century, shortly after the ﬁrst isolation of
the bacterium. Dissemination across large distances was
well-recognized by the beginning of the twentieth century,
particularly among the military, in which small outbreaks
were observed periodically. The ﬁrst clear mention of the
disease as associated with travel dates from 1898, when
several authors describe outbreaks in ships carrying Indian
laborers from Calcutta to East Africa and the West Indies
(speciﬁcally Jamaica and the then British Guyana). Fol-
lowing the increased development of institutions of public
health and epidemiology in the United States, an epidemic
of meningococcal disease in Asia in 1928-1929 was tied to
cases in the West Coast, carried by steerage passengers
from the Philippines. In addition to new rules for steerage,
the National Origins Formula of 1929 drastically restricted
immigration and travel from Asia to the US.
Conclusion: Literature about travel and meningococcal
disease shows clear evidence of risks to travelers for at least
110 years. The long-standing nature of invasive meningococ-
cal disease as a human-speciﬁc pathogen causing potentially
fatal illness is of interest when investigating new options for
prevention and control.
doi:10.1016/j.ijid.2010.02.1795
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Free living amoebae encephalitis infection in a child who
travelled to Peru
C.A. Mora ∗, N. Orellana, A. Schteinschnaider, N. Arakaki,
M. Del CastilloFLENI, Buenos Aires, Argentina
Background: An 8 year-old Hispanic boy who was living in
Argentina, travelled to Perú in December 2008 to visit some
l
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ats e141
elatives. He had chicken pox when he was 4 years old, and
he family medical history was positive for tuberculosis in
he patientˇıs father.
Methods: One week before coming back to Argentina
e experienced cough and low grade fever for which he
as treated: Ibuprofen and amoxicillin. Nine days after he
as back from Peru, he experienced headaches, vomiting.
is parents noticed mild right ptosis, he developed acute
taxia. MRI ﬁndings: two ring-enhancing lesions, one in the
eft occipital area and other one in the brain stem. Spinal
ap: CSF: cell/mm3, Glucose level: 58mg/dl,Protein level:
.38mg/dl. PCR assays for HVS-VZV and cultures for bacte-
ial, mycobacterial and fungal were negative.
Results: Serologic studies: HIV(-),ELISA Cysticercus(-),
gM Mycoplasma (-), IgG Mycoplasma (+), ID Histoplasma
-).PPD 2 UT (-) Preliminary diagnosis was Acute Dissemi-
ated Encephalomyelitis which was treated with parenteral
teroids. He showed no improvement, he started treatment
ith intravenous immunoglobulin. The patient showed dete-
ioration: MRI showed that the lesions had progressed in size.
xcisional biopsy of the occipital lesion was performed. In
he tissue sections there was no evidence of granulomas
ith caseiﬁcation, toxoplasmosis, cysticercosis, fungi and
esmielinization.
The presence of structures with spheroid nucleus and
lear cytoplasm induced to search for amoebas. The
richromic modiﬁed stain Gomori Wheatley showed images
imillar to the ones of the amoebic trophozoites.
He received treatment with pentamidine, rifampicine,
iposomal, amphotericin, sulfamethoxazole trimethoprim,
larithromycin and ﬂuconazol for a period of 60 days.
He remained clinically stable throughout that period but
xperienced gross neurological sequelae. Serial MRI studies
howed gradual resolution of the lesions with a decreased in
ize. After 6 months of ﬁnishing his treatment, at this day
e still remains alive.
Conclusion: Even though the conﬁrmation of the diagno-
is of free-living amoebae encephalitis was not conﬁrmed by
he indirect immunoﬂuorescence assay, the clinical course
f the illness, the imaging studies, the microscopic ﬁndings
nd the fact that he didn’t get worse induces us to believe
hat Granulomatous Amebic Encephalitis is a possible diag-
osis.
oi:10.1016/j.ijid.2010.02.1796
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ew world cutaneous Leishmaniasis in travelers (1994-
008) experience In Argentina
. Orduna1,∗, S. Lloveras1, G.D. Gonzalez1, C.C. Falcone1,
.L. Garro2, S.E. Echazarreta3
Hospital F. J. Mun˜iz, Buenos Aires, Argentina
Hospital F.J. Mun˜iz, Buenos Aires, Argentina
Hospital F.J.Mun˜iz, Buenos Aires, Argentina
Background: Leishmaniasis is a common cause of der-
atosis in returning travelers. The New World cutaneouseishmaniasis (NWCL) is caused by multiple species including
omplexes L (V) braziliensis and L (L) mexicana.
Materials and methods: A retrospective, cross-sectional
nd descriptive analysis was performed based on medical
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eports of travellers with clinical and epidemiological diag-
osis of NWCL, assisted from 1994 through 2008.
Results: 39 cases of NWCL were recorded (29 males, 10
emales, with age ranged from 17 to 72 years). Twenty-nine
74%) patients were residents of Argentina, 10 (26%) were
oreigners in transit. The reason for travel was tourism in 21
54%), work 14 (36%) and friends and relatives visit (VFR) 4
10%).
26 patients (67%) acquired the disease outside Argentina;
3 (33%) in Argentina, who were domestic travelers to
ndemic areas.
At query time 16 (41%) patients had lesions 30 to 60 days
f development, 19 (49%) 75 to 120 days.
Estimated average time of exposure in risk area was 20
ays.
Thirty patients (77%) had multiple lesions and 9 (23%) had
ingle lesion.
84.61% of the lesions were ulcers; 67% of the lesions were
ocalized in the extremities, 23% of the face and 10% in
runk.
The diagnosis was made by direct microscopic examina-
ion in 29 (74%), and 10 (26%) by biopsy, 7 were cultured
5 were positive). No species identiﬁcation was made in
ither case. 36 patients received as ﬁrst treatment sched-
le meglumine antimoniate intramuscular (20mg/kg/day
or 21 days), 2 patients amphotericin B deoxycholate
.5mg/kg/day up to 1,5 grams total and 1 patient who trav-
lled around Panama received ﬂuconazole 200mg/day for 6
eeks. 4 patients treated with meglumine antimoniate had
dverse effects.
85% of patients cured with ﬁrst therapeutic regimen.
3 patients treated with antimonials reported relapses,
ne patient had therapeutic failure. All healed without sub-
equent relapse.
Conclusion: Cutaneous leishmaniasis is a risk for travelers
o tropical areas of America and is necessary to include pre-
ention guidelines in pre travel advisory. It is important that
hysician be trained in the recognition of this condition and
onsider the possibility of mucosal involvement in patients
nfected with L braziliensis.
oi:10.1016/j.ijid.2010.02.1797
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mported malaria in travelers assisted in Buenos Aires
. Lloveras1,∗, S.E. Echazarreta2, S.L. Garro3, C.C.
alcone4, G.D. Gonzalez4, T. Orduna1
Corunna, Argentina
Hospital F.J.Mun˜iz, Buenos Aires, Argentina
Hospital F.J. Mun˜iz, Buenos Aires, Argentina
Hospital F. J. Mun˜iz, Buenos Aires, Argentina
Background: Malaria is the most important parasitic
nfection that produces human disease. It is caused by pro-
ozoa of the genus Plasmodium and transmitted by the bite
f the female Anopheles mosquito. It’s endemic in over 90
ountries and is the most common speciﬁc etiologic diagno-
is in febrile travelers.
Methods: A retrospective, cross-sectional and descriptive
nalysis was performed based on medical reports of trav-
o
m
c
v
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llers with diagnosis of imported malaria, assisted from 1981
hrough 2008.
Results: Of 1010 returned travelers (domestic and inter-
ational) seen at our clinic, 337 (36.36%) patients cited fever
s a chief reason for seeking care and 143 (42.43%) of them
ad malaria.
There were 135 (94.40%) cases of imported malaria, 100
74.07%) males and 35 (25.92%) females, from 3 to 73 years.
27 (94.07%) travelers were residents.
The species involved was P. vivax in 61 cases (46.18%), P.
alciparum in 59 (43.70%); P.ovale in 1 (0.74%), mixed infec-
ions of P. falciparum and vivax malaria in 3 (2.22%) and 11
ases (8.14%) without identiﬁcation.
74 (54.81%) travelers acquired malaria in Africa, 48
35.55%) in South America, and 7 (5.18%) in Central America.
The reasons for travel were: 56 (41.48%) work/business;
7 (34.81%) tourism; 18 (13.33%) visiting friends and rela-
ives; 13 (9.62%) missionary/volunteer; and 1 (0.74%) per
ducation. In travelers to Africa the species most frequently
nvolved was P. falciparum (52/74, 70.27%) and P. vivax in
outh America (38/48, 79.16%).
Only 40 (2.96%) travelers received medical advice before
he trip, of them 32 (80%) received chemoprophylaxis for
alaria, 3 (9.37%) of which were inappropriate according
o the area visited. None of the chemoprophylaxis included
rimaquine. All patients improved with treatment. 5 / 59
8.47%) travelers had P. falciparum severe malaria.
Conclusion: In febrile returned traveler, we must always
onsider the diagnosis of malaria regardless of the time
lapsed since leaving the malaria area. Plasmodium fal-
iparum malaria is a medical emergency. The treatment
epends on the knowledge of the geographical distribution
f parasite resistance against antimalarial drugs, especially
hen no parasite species identiﬁcation is possible.
It should be emphasized prevention with personal pro-
ection measures and adequate chemoprophylaxis.
oi:10.1016/j.ijid.2010.02.1798
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ravel medicine working group
. Macchi1,∗, A. Lepetic2, C. Biscayart1, P. Elmassian1, V.
erdaguer1, M.P. Della Latta1, C. Torroija1, E. Sturba3, M.
rrestia1, D. Stamboulian4
Centros Medicos Dr. Stamboulian, Buenos Aires, Argentina
GSK, Corunna, Argentina
FUNCEI, BUENOS AIRES, Argentina
FUNCEI; Clinical Director, Ciudad Autonoma de Buenos
ires, Argentina
Background: Travel Medicine Working Group (TMWG),
stablished in 1992, is the ﬁrst program for prevention
f travel medicine related infectious diseases in Buenos
ires. TMWG aims to improve travelers health and to raise
wareness of its importance to the argentinean public. The
bjective of this presentation is to describe the scope of a
ultidisciplinary TMWG.
Methods: TMWG comprises infectious diseases spe-
ialists, high-tech, up-to-date laboratory facilities and
accination centers. We designed a program aimed to assist
ravellers before departure, en route, after return and to
